We are live on ! Find out more
RUBY

Rubius Therapeutics, Inc
RUBY

Delisted

RUBY was delisted on the 6th of March, 2023.

Back to rankings

76 hedge funds and large institutions have $771M invested in Rubius Therapeutics, Inc in 2019 Q4 according to their latest regulatory filings, with 12 funds opening new positions, 29 increasing their positions, 22 reducing their positions, and 11 closing their positions.

New
Increased
Maintained
Reduced
Closed

33% more funds holding in top 10

Funds holding in top 10: 3 → 4 (+1)

32% more repeat investments, than reductions

Existing positions increased: 29 | Existing positions reduced: 22

22% more capital invested

Capital invested by funds: $632M → $771M (+$139M)

1% more funds holding

Funds holding: 75 → 76 (+1)

9% more first-time investments, than exits

New positions opened: 12 | Existing positions closed: 11

100% less call options, than puts

Call options by funds: $3K | Put options by funds: $950K

Holders
76
Holders Change
+1
Holders Change %
+1.33%
% of All Funds
1.5%
Holding in Top 10
4
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+33.33%
% of All Funds
0.08%
New
12
Increased
29
Reduced
22
Closed
11
Calls
$3K
Puts
$950K
Net Calls
-$947K
Net Calls Change
-$920K

Top Buyers

Rank Fund Capital Flow
1
Capital World Investors
Capital World Investors
California
+$20.5M
2
Fidelity Investments
Fidelity Investments
Massachusetts
+$13.1M
3
AFM
Abbot Financial Management
Massachusetts
+$5.45M
4
EC
EcoR1 Capital
California
+$2.57M
5
Millennium Management
Millennium Management
New York
+$1.79M

Top Sellers

Rank Fund Capital Flow
1
AllianceBernstein
AllianceBernstein
Tennessee
-$26.8M
2
CAM
Cormorant Asset Management
Massachusetts
-$3.86M
3
Jennison Associates
Jennison Associates
New York
-$3.41M
4
Alkeon Capital Management
Alkeon Capital Management
New York
-$3.14M
5
Citadel Advisors
Citadel Advisors
Florida
-$712K
Name Holding Trade Value Shares
Change 		Change in
Stake
N
26
Nuveen
North Carolina
$1.85M +$607K +62,721 +47%
Citadel Advisors
27
Citadel Advisors
Florida
$1.83M -$712K -73,596 -28%
Bank of New York Mellon
28
Bank of New York Mellon
New York
$1.33M +$141K +14,530 +12%
Ameriprise
29
Ameriprise
Minnesota
$1.09M +$279K +28,841 +34%
Morgan Stanley
30
Morgan Stanley
New York
$991K -$324K -33,521 -24%
Goldman Sachs
31
Goldman Sachs
New York
$871K +$238K +24,589 +37%
AGM
32
Alpine Global Management
New York
$730K +$743K +76,814 New
California Public Employees Retirement System
33
California Public Employees Retirement System
California
$711K +$231K +23,887 +47%
TCM
34
Tekla Capital Management
Massachusetts
$650K +$661K +68,373 New
Swiss National Bank
35
Swiss National Bank
Switzerland
$579K +$14.5K +1,500 +3%
WCM
36
Weld Capital Management
New York
$563K +$573K +59,235 New
California State Teachers Retirement System (CalSTRS)
37
California State Teachers Retirement System (CalSTRS)
California
$507K -$4.14K -428 -0.8%
State of Wisconsin Investment Board
38
State of Wisconsin Investment Board
Wisconsin
$498K – – –
AllianceBernstein
39
AllianceBernstein
Tennessee
$432K -$26.8M -2,769,072 -98%
RhumbLine Advisers
40
RhumbLine Advisers
Massachusetts
$431K +$2.94K +304 +0.7%
UBS Group
41
UBS Group
Switzerland
$354K +$264K +27,261 +274%
Barclays
42
Barclays
United Kingdom
$333K +$135K +13,965 +66%
TI
43
Trexquant Investment
Connecticut
$264K +$268K +27,739 New
New York State Common Retirement Fund
44
New York State Common Retirement Fund
New York
$254K -$89K -9,200 -26%
Deutsche Bank
45
Deutsche Bank
Germany
$245K +$82.9K +8,573 +49%
Manulife (Manufacturers Life Insurance)
46
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$219K -$6.92K -715 -3%
ProShare Advisors
47
ProShare Advisors
Maryland
$209K -$34.3K -3,546 -14%
AIG
48
American International Group
New York
$208K -$1.79K -185 -0.8%
LPL Financial
49
LPL Financial
California
$208K +$42.2K +4,361 +25%
Wells Fargo
50
Wells Fargo
California
$184K -$11.1K -1,150 -6%
1
2
3 4

RUBY Hedge Fund Activity: Q4 2019 in Review

76 of the 5,075 institutional investors tracked by Wall St. Rank reported a position in Rubius Therapeutics, Inc (RUBY) for Q4 2019, worth a combined $771M — up 22% from $632M a quarter earlier.

Buyers outnumbered sellers: 12 funds opened new RUBY positions and 11 closed out — a net gain of 1 holder — while 29 added to existing stakes and 22 trimmed.

The largest buyer was Capital World Investors, adding an estimated $20.5M. The largest seller was AllianceBernstein, cutting an estimated $26.8M.

  • 76 institutional investors held Rubius Therapeutics, Inc (RUBY) as of Q4 2019, up from 75 in Q3 2019.
  • Funds reported $771M of Rubius Therapeutics, Inc stock for Q4 2019, up 22% quarter-over-quarter.
  • 12 funds opened new Rubius Therapeutics, Inc positions in Q4 2019 and 11 closed out, a net change of +1 holder.
  • The largest Rubius Therapeutics, Inc buyer in Q4 2019 was Capital World Investors, an estimated $20.5M added.
  • The largest Rubius Therapeutics, Inc seller in Q4 2019 was AllianceBernstein, an estimated $26.8M sold.

Based on aggregated 13F filings for Q4 2019.